Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Salk's NOMIS Center receives $9.5 million to grow and expand in health, immunity research

As we endure a global viral pandemic, our appreciation for health and immunity has never been greater. Now, thanks to a generous gift from the NOMIS Foundation, Salk's NOMIS Center for Immunobiology and Microbial Pathogenesis will receive $9.5 million to grow and expand, while continuing to be a leader in health and immunity research.

29 Jan 2021

Scientists unravel how lipids distribute proteins within cells

An international team of scientists, coordinated by the Seville Institute of Biomedicine and the University of Seville has solved one of the hitherto unresolved enigmas of basic biology: how exactly do lipids distribute proteins within a cell? To do this, they used a new, completely innovative microscopy technology, which they applied to "mutant" cells they designed in their laboratory.

29 Jan 2021

Early plasma markers help track the progression of Alzheimer's disease

A Quebec research team has discovered two early plasma markers to detect Alzheimer's disease five years before its onset.

28 Jan 2021

Neurological and psychiatric complications six months after COVID-19 recovery

Researchers in the United Kingdom have aimed to determine the prevalence of patients who experience neurological and psychiatric conditions six months after recovering from COVID-19.

28 Jan 2021

Researchers figure out how the immune system keeps tabs on the brain

Alzheimer's disease, multiple sclerosis, autism, schizophrenia and many other neurological and psychiatric conditions have been linked to inflammation in the brain.

27 Jan 2021

New trial to look at reducing transmission of Covid-19 in care homes

A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.

27 Jan 2021

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

The National Institute of Aging, part of the National Institutes of Health, and the Alzheimer's Drug Discovery Foundation awarded five-year grants of $3.2 million and $1.4 million, respectively, to scientists from Cleveland Clinic Lou Ruvo Center for Brain Health to study the therapeutic potential of the anti-cancer drug lenalidomide in early-stage Alzheimer's disease, known as mild cognitive impairment.

27 Jan 2021

Salk scientists receive $1.2 million from Larry L. Hillblom Foundation to study aging mechanisms

A collaborative team of Salk scientists led by Professor John Reynolds will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine aging across the life span, including age-related neurodegenerative diseases such as Alzheimer's disease.

27 Jan 2021

If I have cancer, dementia or MS, should i get the covid vaccine?

As public demand grows for limited supplies of covid-19 vaccines, questions remain about the vaccines' appropriateness for older adults with various illnesses.

27 Jan 2021

New study provides both good and bad news about transient ischemic attacks

Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.

27 Jan 2021

New NIH grant supports research on Alzheimer's disease caused by gene mutations

A new grant from the National Institute On Aging at the National Institutes of Health will support ongoing research at Rensselaer Polytechnic Institute to address Alzheimer's disease caused by gene mutations.

26 Jan 2021

New study to examine the role of extended family caregivers of people with dementia

Karen Roberto and Tina Savla, both core faculty members of Virginia Tech's Center for Gerontology, are leading a five-year, $2.14 million study that will examine the role of extended family caregivers and their service use, needs, and challenges.

26 Jan 2021

Microglial cells contribute to the negative mood experienced during neurological diseases

Special immune cells found in the brain, microglia, play a key role in the processes that make you feel uneasy and depressed in correlation with inflammation.

26 Jan 2021

Study shows link between early brainstem tau accumulation and cortical hyperexcitability

Study conducted by researchers from the GIGA CRC In vivo Imaging laboratory at ULiège demonstrates, for the first time in humans, how the first deposits of tau proteins in the brainstem are associated with neurophysiological processes specific to the early stages of Alzheimer's disease development.

25 Jan 2021

Older people in Japan have "attitude of gratitude" which makes them more optimistic

Older people in Japan have an "attitude of gratitude" which keeps them feeling hopeful despite the challenges of aging, a new study says.

21 Jan 2021

Major surgery is a promoter or accelerator of Alzheimer's disease, indicates study

A new study published in the Journal of Alzheimer's Disease carried out by researchers at the Marqués de Valdecilla-IDIVAL University Hospital, in collaboration with researchers at the University of Bonn Medical Center, proposes that major surgery is a promoter or accelerator of Alzheimer's disease (AD).

21 Jan 2021

Abnormal hyperactivation in the brain could be an early biomarker of Alzheimer's disease

Abnormally hyperactive areas in the brain may help better predict the onset of Alzheimer's disease, according to findings of a research team led by Université de Montreal psychology professor Sylvie Belleville, scientific Director of the Institut universitaire de gériatrie de Montréal research centre.

21 Jan 2021

Idiopathic intracranial hypertension is on the rise, finds study

A new study has found a brain pressure disorder called idiopathic intracranial hypertension is on the rise, and the increase corresponds with rising obesity rates.

20 Jan 2021

Automated method tracks cortical origin and initial spread of TAU proteins in Alzheimer’s disease

Researchers have developed an automated method that can track the development of harmful clumps of TAU protein related to Alzheimer's disease in the brain, according to work involving 443 individuals.

20 Jan 2021

Hematopoietic stem cell transplants may prevent worsening of MS disability

A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment.

20 Jan 2021

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Salk's NOMIS Center receives $9.5 million to grow and expand in health, immunity research

Scientists unravel how lipids distribute proteins within cells

Early plasma markers help track the progression of Alzheimer's disease

Neurological and psychiatric complications six months after COVID-19 recovery

Researchers figure out how the immune system keeps tabs on the brain

New trial to look at reducing transmission of Covid-19 in care homes

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

Salk scientists receive $1.2 million from Larry L. Hillblom Foundation to study aging mechanisms

If I have cancer, dementia or MS, should i get the covid vaccine?

New study provides both good and bad news about transient ischemic attacks

New NIH grant supports research on Alzheimer's disease caused by gene mutations

New study to examine the role of extended family caregivers of people with dementia

Microglial cells contribute to the negative mood experienced during neurological diseases

Study shows link between early brainstem tau accumulation and cortical hyperexcitability

Older people in Japan have "attitude of gratitude" which makes them more optimistic

Major surgery is a promoter or accelerator of Alzheimer's disease, indicates study

Abnormal hyperactivation in the brain could be an early biomarker of Alzheimer's disease

Idiopathic intracranial hypertension is on the rise, finds study

Automated method tracks cortical origin and initial spread of TAU proteins in Alzheimer’s disease

Hematopoietic stem cell transplants may prevent worsening of MS disability

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in